TCR2 THERAPEUTICS INC. Quarterly Assets in USD from Q4 2018 to Q1 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Tcr2 Therapeutics Inc. quarterly Assets history and growth rate from Q4 2018 to Q1 2023.
Tcr2 Therapeutics Inc. Assets for the quarter ending March 31, 2023 was $152M, a 53.1% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2023	$152M	-$172M	-53.1%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$208M	-$115M	-35.6%	Dec 31, 2022	10-Q	2023-05-11
Q3 2022	$273M	-$73.8M	-21.3%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$308M	-$60.1M	-16.3%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$323M	-$72.9M	-18.4%	Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$323M	+$77.2M	+31.3%	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$347M	+$85.9M	+32.9%	Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$368M	+$228M	+162%	Jun 30, 2021	10-Q	2021-08-05
Q1 2021	$396M	+$243M	+158%	Mar 31, 2021	10-Q	2021-05-13
Q4 2020	$246M	+$77.7M	+46.1%	Dec 31, 2020	10-K	2022-03-22
Q3 2020	$261M	+$81.3M	+45.3%	Sep 30, 2020	10-Q	2020-11-12
Q2 2020	$140M	-$49.9M	-26.2%	Jun 30, 2020	10-Q	2020-08-12
Q1 2020	$153M	-$44.6M	-22.5%	Mar 31, 2020	10-Q	2020-05-14
Q4 2019	$169M	+$39.1M	+30.2%	Dec 31, 2019	10-K	2021-03-16
Q3 2019	$180M			Sep 30, 2019	10-Q	2019-11-12
Q2 2019	$190M			Jun 30, 2019	10-Q	2019-08-09
Q1 2019	$198M			Mar 31, 2019	10-Q	2019-05-13
Q4 2018	$129M			Dec 31, 2018	10-K	2020-03-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.